Obstructive sleep apnoea and type 2 diabetes mellitus: A bidirectional association

R. Nisha Aurora, Naresh M Punjabi

Research output: Contribution to journalArticle

Abstract

Obstructive sleep apnoea and type 2 diabetes are common medical disorders that have important clinical, epidemiological, and public health implications. Research done in the past two decades indicates that obstructive sleep apnoea, through the effects of intermittent hypoxaemia and sleep fragmentation, could contribute independently to the development of insulin resistance, glucose intolerance, and type 2 diabetes. Conversely, type 2 diabetes might increase predisposition to, or accelerate progression of, obstructive and central sleep apnoea, possibly through the development of peripheral neuropathy and abnormalities of ventilatory and upper airway neural control. Although more research is needed to clarify the mechanisms underlying the bidirectional association between the two disorders, their frequent coexistence should prompt all health-care professionals to embrace clinical practices that include screening of a patient presenting with one disorder for the other. Early identification of obstructive sleep apnoea in patients with metabolic dysfunction, including type 2 diabetes, and assessment for metabolic abnormalities in those with obstructive sleep apnoea could reduce cardiovascular disease risk and improve the quality of life of patients with these chronic diseases.

Original languageEnglish (US)
Pages (from-to)329-338
Number of pages10
JournalThe Lancet Respiratory Medicine
Volume1
Issue number4
DOIs
StatePublished - Jun 2013

Fingerprint

Obstructive Sleep Apnea
Type 2 Diabetes Mellitus
Central Sleep Apnea
Airway Management
Sleep Deprivation
Glucose Intolerance
Peripheral Nervous System Diseases
Research
Insulin Resistance
Chronic Disease
Cardiovascular Diseases
Public Health
Quality of Life
Delivery of Health Care

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Obstructive sleep apnoea and type 2 diabetes mellitus : A bidirectional association. / Aurora, R. Nisha; Punjabi, Naresh M.

In: The Lancet Respiratory Medicine, Vol. 1, No. 4, 06.2013, p. 329-338.

Research output: Contribution to journalArticle

@article{ddb49b42a7e148f28091a232c7c4040b,
title = "Obstructive sleep apnoea and type 2 diabetes mellitus: A bidirectional association",
abstract = "Obstructive sleep apnoea and type 2 diabetes are common medical disorders that have important clinical, epidemiological, and public health implications. Research done in the past two decades indicates that obstructive sleep apnoea, through the effects of intermittent hypoxaemia and sleep fragmentation, could contribute independently to the development of insulin resistance, glucose intolerance, and type 2 diabetes. Conversely, type 2 diabetes might increase predisposition to, or accelerate progression of, obstructive and central sleep apnoea, possibly through the development of peripheral neuropathy and abnormalities of ventilatory and upper airway neural control. Although more research is needed to clarify the mechanisms underlying the bidirectional association between the two disorders, their frequent coexistence should prompt all health-care professionals to embrace clinical practices that include screening of a patient presenting with one disorder for the other. Early identification of obstructive sleep apnoea in patients with metabolic dysfunction, including type 2 diabetes, and assessment for metabolic abnormalities in those with obstructive sleep apnoea could reduce cardiovascular disease risk and improve the quality of life of patients with these chronic diseases.",
author = "Aurora, {R. Nisha} and Punjabi, {Naresh M}",
year = "2013",
month = "6",
doi = "10.1016/S2213-2600(13)70039-0",
language = "English (US)",
volume = "1",
pages = "329--338",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Obstructive sleep apnoea and type 2 diabetes mellitus

T2 - A bidirectional association

AU - Aurora, R. Nisha

AU - Punjabi, Naresh M

PY - 2013/6

Y1 - 2013/6

N2 - Obstructive sleep apnoea and type 2 diabetes are common medical disorders that have important clinical, epidemiological, and public health implications. Research done in the past two decades indicates that obstructive sleep apnoea, through the effects of intermittent hypoxaemia and sleep fragmentation, could contribute independently to the development of insulin resistance, glucose intolerance, and type 2 diabetes. Conversely, type 2 diabetes might increase predisposition to, or accelerate progression of, obstructive and central sleep apnoea, possibly through the development of peripheral neuropathy and abnormalities of ventilatory and upper airway neural control. Although more research is needed to clarify the mechanisms underlying the bidirectional association between the two disorders, their frequent coexistence should prompt all health-care professionals to embrace clinical practices that include screening of a patient presenting with one disorder for the other. Early identification of obstructive sleep apnoea in patients with metabolic dysfunction, including type 2 diabetes, and assessment for metabolic abnormalities in those with obstructive sleep apnoea could reduce cardiovascular disease risk and improve the quality of life of patients with these chronic diseases.

AB - Obstructive sleep apnoea and type 2 diabetes are common medical disorders that have important clinical, epidemiological, and public health implications. Research done in the past two decades indicates that obstructive sleep apnoea, through the effects of intermittent hypoxaemia and sleep fragmentation, could contribute independently to the development of insulin resistance, glucose intolerance, and type 2 diabetes. Conversely, type 2 diabetes might increase predisposition to, or accelerate progression of, obstructive and central sleep apnoea, possibly through the development of peripheral neuropathy and abnormalities of ventilatory and upper airway neural control. Although more research is needed to clarify the mechanisms underlying the bidirectional association between the two disorders, their frequent coexistence should prompt all health-care professionals to embrace clinical practices that include screening of a patient presenting with one disorder for the other. Early identification of obstructive sleep apnoea in patients with metabolic dysfunction, including type 2 diabetes, and assessment for metabolic abnormalities in those with obstructive sleep apnoea could reduce cardiovascular disease risk and improve the quality of life of patients with these chronic diseases.

UR - http://www.scopus.com/inward/record.url?scp=84880027516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880027516&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(13)70039-0

DO - 10.1016/S2213-2600(13)70039-0

M3 - Article

C2 - 24429158

AN - SCOPUS:84880027516

VL - 1

SP - 329

EP - 338

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

SN - 2213-2600

IS - 4

ER -